Gastrointestinal Cancer,Pancreatic Cancer NCI-MATCH Phase II: Tolerable TRAEs from Vismdegib Oral Intake Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 eNRGy Study: Zenocutuzumab for NRG1+ Cancers Assessment Mar 27, 2023
Gastrointestinal Cancer,Pancreatic Cancer Phase 2 Study: Rucaparib-resistant BRCA/PALB2 Pancreatic Cancer Treatment Mar 27, 2023
Gastrointestinal Cancer Cabozantinib Plus Durvalumab in Advanced GI Cancers: CAMILLA Trial Results Mar 23, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Residual Disease Kinetics in High-Risk CLL Patients: Ibr+Ven vs Clb+O Mar 23, 2023
